Anthony R. Mato, MD¹, John M. Pagel, MD PhD², Catherine C. Coombs, MD³, Nirav N. Shah, MD⁴, Nicole Lamanna, MD⁵, Ewa Lech-Marańda, MD, PhD^6*, Toby A. Eyre^7*, Jennifer A. Woyach, MD⁸, William G. Wierda, MD, PhD⁹, Chan Yoon Cheah, MBBS¹⁰, Lindsey E Roeker, MD¹, Manish R. Patel, MD¹¹, Bita Fakhri, MD, MPH¹², Minal Barve, MD^13*, Constantine S. Tam, MBBS¹⁴, David John Lewis, MD^15*, James N. Gerson, MD¹⁶, Alvaro J. Alencar, MD¹⁷, Justin Taylor, MD¹⁷, Omar Abdel-Wahab, MD ¹, Paolo Ghia, MD, PhD¹⁸, Stephen J. Schuster, MD¹⁶, Jessica Chen, MS^19*, Binoj Nair, PhD^19*, Donald Tsai, MD, PhD¹⁹, Nora C. Ku, MD^19*, Matthew S. Davids, MD²⁰, Jennifer R Brown, MD, PhD²⁰ and Wojciech Jurczak, MD, PhD²¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
³Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁴Medical College of Wisconsin, Brookfield, WI
⁵Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
⁶Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
⁷Churchill Cancer Center, Oxford University Hospitals NHS Foundation Trust, Old Road, United Kingdom
⁸The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia
¹¹Florida Cancer Specialists / Sarah Cannon Research Institute, Sarasota, FL
¹²Division of Hematology and Oncology, University of California, San Francisco, CA
¹³Mary Crowley Cancer Research, Dallas, TX
¹⁴Peter MacCallum Cancer Center, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC, Australia
¹⁵Plymouth Hospitals NHS Trust - Derriford Hospital, Plymouth, United Kingdom
¹⁶Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁷Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
¹⁸Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, MI, Italy
¹⁹Loxo Oncology at Lilly, Stamford, CT
²⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²¹Department of Hematology, Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland

John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath¹, Wojciech Jurczak, MD, PhD², Ryan Jacobs, MD³, Sebastian Grosicki, MD, PhD⁴, Krzysztof Giannopoulos, MD, PhD⁵, Tomasz Wrobel, MD PhD⁶, Syed F. Zafar, MD⁷, Jennifer L. Cultrera, MD⁸, Suman Kambhampati, MD^9*, Alexey Danilov, MD¹⁰, John M. Burke, MD¹¹, Jerome Goldschmidt, MD^12*, Douglas F. Beach, MD¹³, Scott F. Huntington, MD, MPH¹⁴, Javier Pinilla Ibarz, MD, PhD¹⁵, Jeff P Sharman, MD¹⁶, Tanya Siddiqi, MD¹⁷, Danielle M. Brander, MD¹⁸, John M. Pagel, MD PhD¹⁹, Kathryn S. Kolibaba, MD²⁰, Monika Dlugosz-Danecka, MD, PhD^2*, Nilanjan Ghosh, MD, PhD²¹, Peter Sportelli, BS ²², Hari P. Miskin, MSc^22*, Owen A. O'Connor, MD, PhD²², Michael S. Weiss^22* and Ian W. Flinn, MD, PhD²³

¹Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
²Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
³Department of Hematology, Lymphoma Division, Department of Hematology, Lymphoma Division, Assistant Professor of Medicine, Levine Cancer Institute/Atrium Health, Charlotte, NC
⁴Department of Hematology and Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland
⁵Medical Univ. of Lublin, Lublin, Poland
⁶Department of Hematology, Wroclaw Medical University, Wroclaw, Poland
⁷Florida Cancer Specialists South / Sarah Cannon Research Institute, Fort Myers, FL
⁸Florida Cancer Specialists North / Sarah Cannon Research Institute, St. Petersburg, FL
⁹Sarah Cannon Research Institute At Research Medical Ctr, Kansas City, MO
¹⁰Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹¹US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO
¹²Blue Ridge Cancer Centers / US Oncology Research, Blacksburg, VA
¹³Pennsylvania Hospital, Philadelphia, PA
¹⁴Yale Cancer Center, New Haven, CT
¹⁵Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
¹⁶Willamette Valley Cancer Institute and US Oncology Research, Eugene, OR
¹⁷Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹⁸Duke Cancer Institute, Duke University Health System, Durham, NC
¹⁹Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
²⁰Northwest Cancer Specialists, Yacolt, WA
²¹Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, NC
²²TG Therapeutics, Inc., New York, NY
²³Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN

William G. Wierda, MD, PhD¹, Kathleen A. Dorritie, MD², Javier Munoz, MD³, Deborah M. Stephens, DO⁴, Scott R. Solomon, MD⁵, Heidi H. Gillenwater, MD^6*, Lucy Gong, PharmD^6*, Lin Yang, PhD^6*, Ken Ogasawara, PhD, MPH^7*, Jerill Thorpe, BS^6* and Tanya Siddiqi, MD^8*

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²UPMC Hillman Cancer Center, Pittsburgh, PA
³Banner MD Anderson Cancer Center, Gilbert, AZ
⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵Immunotherapy Program, Northside Hospital Cancer Institute, Atlanta, GA
⁶Juno Therapeutics, a Bristol-Myers Squibb Company, Seattle, WA
⁷Bristol-Myers Squibb Company, Princeton, NJ
⁸City of Hope National Medical Center, Duarte, CA

Ohad Benjamini^1,2*, Avichai Shimoni, MD^1,2*, Michal Besser, PhD^3,4*, Noga Shem-Tov, MD^1,2*, Ivetta Danylesko, MD^1,2*, Ronit Yerushalmi, MD^1,2, Drorit Grizim Merkel, MD^1,2, Tamar Tadmor, MD^5*, David Lavie, MD^6*, Riva Fineman, MD^7*, Elad Jacobi, MD^2,8*, Arnon Nagler, MD^1,9 and Abraham Avigdor, MD^1,2

¹Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel
²Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
³Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel-Aviv, Israel
⁴Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat-Gan, Israel
⁵Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
⁶Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
⁷Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
⁸Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
⁹Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Tanya Siddiqi, MD^1*, Jacob D. Soumerai, MD², Kathleen A. Dorritie, MD³, Deborah M. Stephens, DO⁴, Peter A. Riedell, MD⁵, Jon E. Arnason, MD⁶, Thomas J. Kipps, MD, PhD⁷, Heidi H. Gillenwater, MD^8*, Lucy Gong, PharmD^8*, Lin Yang, PhD^8*, Ken Ogasawara, PhD, MPH^9* and William G. Wierda, MD, PhD¹⁰

¹City of Hope National Medical Center, Duarte, CA
²Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
³UPMC Hillman Cancer Center, Pittsburgh, PA
⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵University of Chicago Medical Center, Chicago, IL
⁶Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁷Moores Cancer Center, University of California, San Diego, San Diego, CA
⁸Juno Therapeutics, a Bristol-Myers Squibb Company, Seattle, WA
⁹Bristol-Myers Squibb Company, Princeton, NJ
¹⁰The University of Texas MD Anderson Cancer Center, Houston, TX

Anthony R. Mato, MD¹, Jacqueline C. Barrientos, MD², Jeff P Sharman, MD³, Danielle M. Brander, MD⁴, Meghan Gutierrez, BA^5*, Karen Kadish, MSN^6*, Israel Arango-Hisijara, MD^7*, Sandhya Upasani^7*, Jennifer Han, PharmD, MBA^8*, Qing Huang, PhD^8*, Reethi Iyengar, PhD^7* and Nilanjan Ghosh, MD, PhD⁹

¹CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Northwell Health Cancer Institute, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
³Willamette Valley Cancer Institute & Research Center, Eugene, OR
⁴Duke University Health System, Durham, NC
⁵Lymphoma Research Foundation, New York, NY
⁶Tufts Medical Center, Boston, MA
⁷Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
⁸Janssen Scientific Affairs, LLC, Horsham, PA
⁹Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, NC